These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34303004)

  • 21. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.
    Robinson S; Kiddy D; Gelding SV; Willis D; Niththyananthan R; Bush A; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):351-5. PubMed ID: 8222298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA; Elkind-Hirsch KE; Malinak R
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
    Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
    Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
    Mango D; Ricci S; Manna P; Miggiano GA; Serra GB
    Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study.
    Tagliaferri V; Romualdi D; Scarinci E; Cicco S; Florio CD; Immediata V; Tropea A; Santarsiero CM; Lanzone A; Apa R
    Reprod Sci; 2018 Feb; 25(2):269-275. PubMed ID: 28558523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasonography in Liver Vascular Disease.
    De Gottardi A; Berzigotti A; Buscarini E; García Criado A
    Ultraschall Med; 2018 Aug; 39(4):382-405. PubMed ID: 30071557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient hepatic attenuation differences (THAD) not connected to focal lesions.
    Colagrande S; Carmignani L; Pagliari A; Capaccioli L; Villari N
    Radiol Med; 2002; 104(1-2):25-43. PubMed ID: 12386553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with mesocaval shunt with autologous jugular vein interposition in patients with Budd-Chiari syndrome.
    Ilkgul O; Kilic M; Içöz G; Zeytunlu M; Demirpolat G; Akyildiz M; Tokat Y; Parildar M; Memis A
    Hepatogastroenterology; 2005; 52(63):662-5. PubMed ID: 15966177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.
    Kiddy DS; Hamilton-Fairley D; Bush A; Short F; Anyaoku V; Reed MJ; Franks S
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):105-11. PubMed ID: 1559293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical and interventional radiological treatment of Budd-Chiari syndrome: report of nine cases.
    Malkowski P; Michalowicz B; Pawlak J; Wroblewski T; Grzelak I; Pacho R; Rowinski O; Leowska E; Smoter P; Szczerban J; Paczkowska AK; Krawczyk M
    Hepatogastroenterology; 2003; 50(54):2049-51. PubMed ID: 14696463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The reason and treatment of portal vein thrombosis in patients with portal hypertension postoperation].
    Wang MC; Li S; Zhu JY; Leng XS; Du RY
    Zhonghua Wai Ke Za Zhi; 2004 Mar; 42(5):269-71. PubMed ID: 15062013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
    Stabile G; Borrielli I; Artenisio AC; Bruno LM; Benvenga S; Giunta L; La Marca A; Volpe A; Pizzo A
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
    Devenport MH; Crook D; Wynn V; Lees LJ
    Br J Clin Pharmacol; 1989 Jun; 27(6):851-9. PubMed ID: 2547410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome.
    Elting MW; Korsen TJ; Schoemaker J
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):767-76. PubMed ID: 11895219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular liver diseases: A sex-oriented analysis of the literature.
    Zanetto A; Cossiga V; Shalaby S; Guarino M; Invernizzi F; Lapenna L; Becchetti C; Morisco F; Morelli MC; Merli M; Toniutto P; Burra P;
    Dig Liver Dis; 2023 Feb; 55(2):178-186. PubMed ID: 35906168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of at-risk hyperandrogenism by age and race/ethnicity among females in the United States using NHANES III.
    Dubey P; Reddy SY; Alvarado L; Manuel SL; Dwivedi AK
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():189-197. PubMed ID: 33838556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.